Literature DB >> 24109227

Efficiency of cell-free and cell-associated virus in mucosal transmission of human immunodeficiency virus type 1 and simian immunodeficiency virus.

Dror Kolodkin-Gal1, Sandrine L Hulot, Birgit Korioth-Schmitz, Randi B Gombos, Yi Zheng, Joshua Owuor, Michelle A Lifton, Christian Ayeni, Robert M Najarian, Wendy W Yeh, Mohammed Asmal, Gideon Zamir, Norman L Letvin.   

Abstract

Effective strategies are needed to block mucosal transmission of human immunodeficiency virus type 1 (HIV-1). Here, we address a crucial question in HIV-1 pathogenesis: whether infected donor mononuclear cells or cell-free virus plays the more important role in initiating mucosal infection by HIV-1. This distinction is critical, as effective strategies for blocking cell-free and cell-associated virus transmission may be different. We describe a novel ex vivo model system that utilizes sealed human colonic mucosa explants and demonstrate in both the ex vivo model and in vivo using the rectal challenge model in rhesus monkeys that HIV-1-infected lymphocytes can transmit infection across the mucosa more efficiently than cell-free virus. These findings may have significant implications for our understanding of the pathogenesis of mucosal transmission of HIV-1 and for the development of strategies to prevent HIV-1 transmission.

Entities:  

Mesh:

Year:  2013        PMID: 24109227      PMCID: PMC3838232          DOI: 10.1128/JVI.03108-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

Review 1.  Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.

Authors:  A D Kashuba; J R Dyer; L M Kramer; R H Raasch; J J Eron; M S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks.

Authors:  D L Sodora; A Gettie; C J Miller; P A Marx
Journal:  AIDS Res Hum Retroviruses       Date:  1998-04       Impact factor: 2.205

Review 3.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

4.  Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys.

Authors:  Jinyan Liu; Brandon F Keele; Hui Li; Sheila Keating; Philip J Norris; Angela Carville; Keith G Mansfield; Georgia D Tomaras; Barton F Haynes; Dror Kolodkin-Gal; Norman L Letvin; Beatrice H Hahn; George M Shaw; Dan H Barouch
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

5.  An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum.

Authors:  Guido Ferrari; Justin Pollara; Daniel Kozink; Tiara Harms; Mark Drinker; Stephanie Freel; M Anthony Moody; S Munir Alam; Georgia D Tomaras; Christina Ochsenbauer; John C Kappes; George M Shaw; James A Hoxie; James E Robinson; Barton F Haynes
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

6.  Selective transmigration of monocyte-associated HIV-1 across a human cervical monolayer and its modulation by seminal plasma.

Authors:  Philip Lawrence; Didier Portran; Rachel Terrasse; Sabine Palle; Thomas Olivier; Jacques Fantini; Thomas Bourlet; Bruno Pozzetto; Olivier Delezay
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

7.  Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy.

Authors:  Joseph A Politch; Kenneth H Mayer; Deborah J Anderson
Journal:  J Acquir Immune Defic Syndr       Date:  2009-03-01       Impact factor: 3.731

8.  Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies.

Authors:  Irene A Abela; Livia Berlinger; Merle Schanz; Lucy Reynell; Huldrych F Günthard; Peter Rusert; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

Review 9.  Avoiding the void: cell-to-cell spread of human viruses.

Authors:  Quentin Sattentau
Journal:  Nat Rev Microbiol       Date:  2008-11       Impact factor: 60.633

10.  Oral keratinocytes support non-replicative infection and transfer of harbored HIV-1 to permissive cells.

Authors:  Anjalee Vacharaksa; Anil C Asrani; Kristin H Gebhard; Claudine E Fasching; Rodrigo A Giacaman; Edward N Janoff; Karen F Ross; Mark C Herzberg
Journal:  Retrovirology       Date:  2008-07-17       Impact factor: 4.602

View more
  32 in total

1.  MIV-150/zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model.

Authors:  Patrick Barnable; Giulia Calenda; Thierry Bonnaire; Radhika Menon; Keith Levendosky; Agegnehu Gettie; James Blanchard; Michael L Cooney; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

2.  Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cells.

Authors:  Shayarana L Gooneratne; Jonathan Richard; Wen Shi Lee; Andrés Finzi; Stephen J Kent; Matthew S Parsons
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

3.  Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.

Authors:  Randi B Gombos; Dror Kolodkin-Gal; Leila Eslamizar; Joshua O Owuor; Emanuele Mazzola; Ana M Gonzalez; Birgit Korioth-Schmitz; Rebecca S Gelman; David C Montefiori; Barton F Haynes; Joern E Schmitz
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

4.  Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones.

Authors:  Hongru Li; Benjamin K Chen
Journal:  Virology       Date:  2018-11-08       Impact factor: 3.616

5.  Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques.

Authors:  Matthew S Parsons; Wen Shi Lee; Anne B Kristensen; Thakshila Amarasena; Georges Khoury; Adam K Wheatley; Arnold Reynaldi; Bruce D Wines; P Mark Hogarth; Miles P Davenport; Stephen J Kent
Journal:  J Clin Invest       Date:  2018-11-26       Impact factor: 14.808

6.  The effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques.

Authors:  Nisha Loganantharaj; Whitney A Nichols; Gregory J Bagby; Julia Volaufova; Jason Dufour; David H Martin; Steve Nelson; Angela M Amedee
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-08       Impact factor: 2.205

7.  Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach.

Authors:  Frederik Graw; Danyelle N Martin; Alan S Perelson; Susan L Uprichard; Harel Dahari
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

Review 8.  Modeling mucosal cell-associated HIV type 1 transmission in vitro.

Authors:  Deborah J Anderson
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

9.  Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission.

Authors:  Corey A Williams-Wietzikoski; Mary S Campbell; Rachel Payant; Airin Lam; Hong Zhao; Hannah Huang; Anna Wald; Wendy Stevens; Glenda Gray; Carey Farquhar; Helen Rees; Connie Celum; James I Mullins; Jairam R Lingappa; Lisa M Frenkel
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

10.  JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope-Mutated HIV-1.

Authors:  Yudong Quan; Hongtao Xu; Yingshan Han; Thibault Mesplède; Mark A Wainberg
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.